Tonghua Dongbao Pharmaceutical Co., Ltd. Price (600867.SS)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

1,979,381,895

(0.4385)%

Tonghua Performance History

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

Tonghua Dongbao Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical products for the treatment of diabetes and cardiovascular-based diseases in China. The company operates through Pharmaceutical Industry and Building Materials Industry segments. Its lead product portfolio includes insulin analogues, such as insulin glargine, Insulin aspart, and insulin lispro; antidiabetic drugs; and oral hypoglycemic drugs, as well as Gan Shulin pens, blood glucose meters, and other medical devices. It offers building materials. The... Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $7.02-11.09
  • Market Cap 14.72B
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Drug Manufacturers - General

  • ceo: Mr. Chun Sheng Leng
  • IPO Date: August, 24, 1994
  • Country: CN
  • Currency: CNY
  • Headquaters: No Data
  • Employees: 3196

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation